Feb 9 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2017 Dec 31, 2016 Dec 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.42 1.39
(-2.2 pct)
Operating loss 150 mln loss 698 mln
Recurring loss 80 mln loss 680 mln
Net
Net loss 58 mln loss 686 mln
EPS loss 2.99 yen loss 33.84 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))